5036 Cytochrome b559 subunits
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organic oxygen compounds | 2 | 6.1 | 0.33× | q = 0.11 | |
| Homogeneous metal compounds | 2 | 15.0 | 0.13× | q < 0.0001 | |
| Homogeneous non-metal compounds | 0 | 6.6 | 0 | q = 3.1e-3 | |
| Nucleosides, nucleotides, and analogues | 0 | 8.5 | 0 | q = 2.1e-4 | |
| Lipids and lipid-like molecules | 31 | 3.4 | 9.11× | not tested | |
| Organoheterocyclic compounds | 4 | 4.7 | 0.85× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB18267 | HEM | Ferroheme | 463 |
| DB02043 | LHG | 1,2-Dipalmitoyl-Phosphatidyl-Glycerole | 282 |
| DB06755 | BCR | Beta carotene | 265 |
| DB03426 | DGD | Digalactosyl Diacyl Glycerol (Dgdg) | 236 |
| DB03193 | STE | Stearic acid | 50 |
| DB03317 | HEC | Ferroheme C | 36 |
| DB04450 | HTG | Heptyl 1-Thiohexopyranoside | 5 |
| DB04735 | MGE | Monogalactosyldiacylglycerol | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| HEM | PROTOPORPHYRIN IX CONTAINING FE | 650 |
| LHG | 1,2-DIPALMITOYL-PHOSPHATIDYL-GLYCEROLE | 350 |
| LMG | 1,2-DISTEAROYL-MONOGALACTOSYL-DIGLYCERIDE | 337 |
| BCR | BETA-CAROTENE | 323 |
| SQD | 1,2-DI-O-ACYL-3-O-[6-DEOXY-6-SULFO-ALPHA-D-GLUCOPYRANOSYL]-SN-GLYCEROL | 304 |
| PL9 | 2,3-DIMETHYL-5-(3,7,11,15,19,23,27,31,35-NONAMETHYL-2,6,10,14,18,22,26,30,34-HEXATRIACONTANONAENYL-2,5-CYCLOHEXADIENE-1,4-DIONE-2,3-DIMETHYL-5-SOLANESYL-1,4-BENZOQUINONE | 244 |
| DGD | DIGALACTOSYL DIACYL GLYCEROL (DGDG) | 121 |
| CLA | CHLOROPHYLL A | 73 |
| CAmetal | CALCIUM ION | 45 |
| UNL | Unknown ligand | 43 |
| STE | STEARIC ACID | 35 |
| HEC | HEME C | 34 |
| 8CT | (6'R,11cis,11'cis,13cis,15cis)-4',5'-didehydro-5',6'-dihydro-beta,beta-carotene | 13 |
| MGE | (1S)-2-(ALPHA-L-ALLOPYRANOSYLOXY)-1-[(TRIDECANOYLOXY)METHYL]ETHYL PALMITATE | 10 |
| 4RF | Tripalmitoylglycerol | 8 |
| PLM | PALMITIC ACID | 8 |
| MGmetal | MAGNESIUM ION | 7 |
| HTG | heptyl 1-thio-beta-D-glucopyranoside | 5 |
| LFA | EICOSANE | 4 |
| WVN | 1,3,3-trimethyl-2-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-[(1R)-2,6,6-trimethylcyclohex-2-en-1-yl]octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohexene | 4 |